Zdrowie i gospodarka · 20/06/2017

FDA Seeks Public Comment on Proposed Collection of Information for Human Drug Compounding Outsourcing Facilities

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to the registration of human drug compounding outsourcing facilities under the Federal Food, Drug, and Cosmetic Act. The FDA must publish this notice in the Federal Register and allow 60 days for public comment in response.